drugset / Trial / NCT00150397

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

NCT00150397 ↗

Phase 2 Completed 112 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma

Timeline

Start
2005-03
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofimilast Small molecule — —

Indications